Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Johnson & Johnson reportedly wants to sell Cerenovus for 1B

February 18, 2025
According to recent reports, Johnson & Johnson is considering selling its Cerenovus stroke business for 1 billion dollars. The company is said to be exploring options to divest this division as part of its ongoing restructuring efforts. Cerenovus, which focuses on developing innovative stroke care solutions, has not performed as well as expected in recent years. This potential sale aims to allow Johnson & Johnson to streamline its operations and focus on more profitable areas of the healthcare sector. Industry experts believe that a sale of this magnitude could attract significant interest from potential buyers looking to expand their presence in the stroke care market. Investors are advised to consult professionals from Stocks Prognosis for a forecast on the future movement of Johnson & Johnson's stocks.

Find out how the JOHNSON & JOHNSON rate is expected to change

Get Forecast for JNJ

Investor opinions & comments:

This sale could create an opportunity for another company to acquire innovative stroke care solutions and make advancements in the field
— from WealthyWalter at 02-21-2025 17:42
I'm excited to see what other areas Johnson & Johnson will focus on after divesting Cerenovus. It could lead to new and exciting developments in the healthcare sector
— from SavvySusan at 02-21-2025 15:22
This sale could lead to increased competition in the stroke care market, benefiting patients and driving innovation in the industry
— from StockSteve at 02-21-2025 11:48
I'm not sure if selling Cerenovus is the best solution for Johnson & Johnson. They should consider investing in improving the performance of the division instead
— from EliWells at 02-21-2025 03:31
Is the $1 billion price tag for Cerenovus justified? It seems like a high amount for a division that hasn't met expectations
— from MikeWilliams at 02-20-2025 23:42
Johnson & Johnson's decision to sell Cerenovus could help them streamline their operations and improve profitability in the healthcare sector
— from EliWells at 02-20-2025 12:17
Johnson & Johnson's restructuring efforts show their commitment to adapt and optimize their operations according to market demands
— from CharlesScott at 02-20-2025 07:38
What if Cerenovus starts performing better in the future? Selling it now could lead to missed opportunities and potential regrets
— from NoraJenkins at 02-19-2025 10:52
This sale could be a great opportunity for Johnson & Johnson to refocus its efforts on more profitable areas
— from GraceStewart at 02-19-2025 03:15
I'm curious to know how this sale will impact Johnson & Johnson's stock prices in the coming months
— from MarketMolly at 02-18-2025 22:28
I wonder if Johnson & Johnson has already received any offers for Cerenovus. It would be interesting to see the potential buyers lining up
— from CapitalChris at 02-18-2025 17:56
It's interesting to see how potential buyers will respond to the sale and if they see value in expanding their presence in the stroke care market
— from JamesThomas at 02-18-2025 06:39
If you want to leave a comment, then you need Login or Register





Other news for JNJ

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....



Related news

CVSFebruary 11, 2025CVS Announces Layoffs of Accountants Amid Restructuring  ~2 min.

CVS Health Corporation has recently announced the layoff of 38 accountants as part of its ongoing restructuring efforts....

CVXFebruary 27, 2025CVX Chevron Corporation: Streamlining Operations for Increased Efficiency  ~2 min.

Energy giant Chevron Corporation (CVX) has recently announced a major restructuring program aimed at streamlining its operations for increased efficiency....

CVXFebruary 25, 2025Chevron Streamlines Operations: Major Restructuring and Leadership Overhaul to Boost Efficiency  ~2 min.

Chevron Corporation, one of the world's largest integrated energy companies, has announced a major restructuring and leadership overhaul aimed at boosting efficiency....

KTJanuary 24, 2025KT to sell financial security unit for 59 mn for restructuring  ~1 min.

KT Corporation, a South Korean telecommunications company, has announced its plans to sell its financial security unit for $59 million....

GMFebruary 18, 2025General Motors to Close Factory in China as Part of Restructuring Plan  ~1 min.

General Motors Company (GM) has announced its decision to close a factory in China as part of its ongoing restructuring efforts in the country....